Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study

Grant

Total Award Amount

  • 730159.00
  • Direct Costs

  • 596122.00
  • Sponsor Award Id

  • R01CA235726
  • Contributor

  • Ellen Smith   Principal Investigator